
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation
Giuseppe Deganutti, Yi-Lynn Liang, Xin Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Giuseppe Deganutti, Yi-Lynn Liang, Xin Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 97
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 97
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification
Vasiliki Lagou, Longda Jiang, Anna Ulrich, et al.
Nature Genetics (2023) Vol. 55, Iss. 9, pp. 1448-1461
Open Access | Times Cited: 50
Vasiliki Lagou, Longda Jiang, Anna Ulrich, et al.
Nature Genetics (2023) Vol. 55, Iss. 9, pp. 1448-1461
Open Access | Times Cited: 50
Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics
Ziva Vuckovic, Jinan Wang, Vi Pham, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 26
Ziva Vuckovic, Jinan Wang, Vi Pham, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 26
GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics
Shane C. Wright, Aikaterini Motso, Stefania Koutsilieri, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Shane C. Wright, Aikaterini Motso, Stefania Koutsilieri, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
New Insights into the Structure and Function of Class B1 GPCRs
Brian P. Cary, Xin Zhang, Jianjun Cao, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 3, pp. 492-517
Open Access | Times Cited: 37
Brian P. Cary, Xin Zhang, Jianjun Cao, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 3, pp. 492-517
Open Access | Times Cited: 37
Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
Jessica Bo Li Lu, Sarah Piper, Peishen Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8069-8069
Open Access | Times Cited: 25
Jessica Bo Li Lu, Sarah Piper, Peishen Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8069-8069
Open Access | Times Cited: 25
An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism
Joshua A. Lees, João M. Dias, Francis Rajamohan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Joshua A. Lees, João M. Dias, Francis Rajamohan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
Stefano Ciardullo, Mario Luca Morieri, GIUSEPPE DANIELE, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 8, pp. 941-950
Open Access | Times Cited: 5
Stefano Ciardullo, Mario Luca Morieri, GIUSEPPE DANIELE, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 8, pp. 941-950
Open Access | Times Cited: 5
Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide–Target Interactions
Yuxin Shi, Yi Chen, Liping Deng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1083-1111
Closed Access | Times Cited: 12
Yuxin Shi, Yi Chen, Liping Deng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1083-1111
Closed Access | Times Cited: 12
Conformational Dynamics of the Activated GLP-1 Receptor-Gs Complex Revealed by Cross-Linking Mass Spectrometry and Integrative Structure Modeling
Shijia Yuan, Lisha Xia, Chenxi Wang, et al.
ACS Central Science (2023) Vol. 9, Iss. 5, pp. 992-1007
Open Access | Times Cited: 12
Shijia Yuan, Lisha Xia, Chenxi Wang, et al.
ACS Central Science (2023) Vol. 9, Iss. 5, pp. 992-1007
Open Access | Times Cited: 12
Structural analysis of the dual agonism at GLP-1R and GCGR
Yang Li, Qingtong Zhou, Antao Dai, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 33
Open Access | Times Cited: 12
Yang Li, Qingtong Zhou, Antao Dai, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 33
Open Access | Times Cited: 12
Molecular insights into peptide agonist engagement with the PTH receptor
Brian P. Cary, Elliot Gerrard, Matthew J. Belousoff, et al.
Structure (2023) Vol. 31, Iss. 6, pp. 668-676.e5
Open Access | Times Cited: 11
Brian P. Cary, Elliot Gerrard, Matthew J. Belousoff, et al.
Structure (2023) Vol. 31, Iss. 6, pp. 668-676.e5
Open Access | Times Cited: 11
Gestational diabetes mellitus-derived miR-7-19488 targets PIK3R2 mRNA to stimulate the abnormal development and maturation of offspring-islets
Chunxue Xu, Linhai Zou, Li Wang, et al.
Life Sciences (2025) Vol. 363, pp. 123369-123369
Closed Access
Chunxue Xu, Linhai Zou, Li Wang, et al.
Life Sciences (2025) Vol. 363, pp. 123369-123369
Closed Access
Biased agonism in peptide-GPCRs: A structural perspective
Tharindunee Jayakody, Dinath Kavishka Budagoda, Krishan Mendis, et al.
Pharmacology & Therapeutics (2025), pp. 108806-108806
Open Access
Tharindunee Jayakody, Dinath Kavishka Budagoda, Krishan Mendis, et al.
Pharmacology & Therapeutics (2025), pp. 108806-108806
Open Access
Prolonged signaling of backbone-modified glucagon‐like peptide‐ 1 analogues with diverse receptor trafficking
Brian P. Cary, Marlies V. Hager, Zamara Mariam, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 14
Open Access
Brian P. Cary, Marlies V. Hager, Zamara Mariam, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 14
Open Access
Where are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeutics
Zoe Tasma, Michael L. Garelja, Aqfan Jamaluddin, et al.
Pharmacology & Therapeutics (2025), pp. 108846-108846
Open Access
Zoe Tasma, Michael L. Garelja, Aqfan Jamaluddin, et al.
Pharmacology & Therapeutics (2025), pp. 108846-108846
Open Access
Structural pharmacology and mechanisms of GLP-1R signaling
Qingtong Zhou, Fenghui Zhao, Y Zhang, et al.
Trends in Pharmacological Sciences (2025)
Closed Access
Qingtong Zhou, Fenghui Zhao, Y Zhang, et al.
Trends in Pharmacological Sciences (2025)
Closed Access
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
Giuseppe Deganutti, Ludovico Pipitò, Roxana M. Rujan, et al.
(2025)
Open Access
Giuseppe Deganutti, Ludovico Pipitò, Roxana M. Rujan, et al.
(2025)
Open Access
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
Giuseppe Deganutti, Ludovico Pipitò, Roxana‐Maria Rujan, et al.
eLife (2025) Vol. 13
Open Access
Giuseppe Deganutti, Ludovico Pipitò, Roxana‐Maria Rujan, et al.
eLife (2025) Vol. 13
Open Access
Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models
Anna Thorsø Larsen, Khaled Elhady Mohamed, Nina Sonne, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113842-113842
Open Access | Times Cited: 16
Anna Thorsø Larsen, Khaled Elhady Mohamed, Nina Sonne, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113842-113842
Open Access | Times Cited: 16
Structure and Molecular Mechanism of Signaling for the Glucagon-like Peptide-1 Receptor Bound to Gs Protein and Exendin-P5 Biased Agonist
Bo Li, Krystyna Maruszko, Soo‐Kyung Kim, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 37, pp. 20422-20431
Open Access | Times Cited: 8
Bo Li, Krystyna Maruszko, Soo‐Kyung Kim, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 37, pp. 20422-20431
Open Access | Times Cited: 8
Implications of ligand-receptor binding kinetics on GLP-1R signalling
Peishen Zhao, Tin T. Truong, Jon Merlin, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 114985-114985
Closed Access | Times Cited: 13
Peishen Zhao, Tin T. Truong, Jon Merlin, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 114985-114985
Closed Access | Times Cited: 13
Differential Responses of the GLP-1 and GLP-2 Receptors to N-Terminal Modification of a Dual Agonist
Ruslan Gibadullin, Brian P. Cary, Samuel H. Gellman
Journal of the American Chemical Society (2023) Vol. 145, Iss. 22, pp. 12105-12114
Open Access | Times Cited: 7
Ruslan Gibadullin, Brian P. Cary, Samuel H. Gellman
Journal of the American Chemical Society (2023) Vol. 145, Iss. 22, pp. 12105-12114
Open Access | Times Cited: 7
Distinct roles of the extracellular surface residues of glucagon-like peptide-1 receptor in β-arrestin 1/2 signaling
Saifei Lei, Qian Meng, Yan‐Yun Liu, et al.
European Journal of Pharmacology (2024) Vol. 968, pp. 176419-176419
Closed Access | Times Cited: 2
Saifei Lei, Qian Meng, Yan‐Yun Liu, et al.
European Journal of Pharmacology (2024) Vol. 968, pp. 176419-176419
Closed Access | Times Cited: 2
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)
Giuseppe Deganutti, Ludovico Pipitò, Roxana M. Rujan, et al.
(2024)
Open Access | Times Cited: 2
Giuseppe Deganutti, Ludovico Pipitò, Roxana M. Rujan, et al.
(2024)
Open Access | Times Cited: 2